Epigenome editing, a CRISPR therapy modulating DNA methylation

Proposal for platform construction and development of drugs for rare genetic diseases

NF-κB inducing kinase (NIK) Novel target for cholangiocarcinoma

Molecular targeted drugs targeting the NIK associated with the differentiation factor from hepatocytes to cholangiocarcinoma

SYT13 Antisense Oligonucleotide for Gastric Cancer Peritoneal Metastasis

Near-term first-in-human ready optimized drug candidate

PeriCyto: A Companion Diagnostics for Immune Checkpoint Inhibitors

Prediction of the efficacy of cancer immunotherapy using the tumor-targeting activity of T cells in peripheral blood.

Efficient method for the production of liposomes containing hydrophilic substances

Efficient encapsulation of hydrophilic small molecules and medium molecular weight drugs such as nucleic acids and peptides in liposomes

Improving the efficiency of exogenous mRNA expression

Overcoming the challenges of mRNA medicine by improving translation efficiency

A whole-animal platform for exploring pancreatic cancer drug and combination therapy thereby

Drosophila models for human PDAC genotype

Antisense Oligonucleotide Therapy for Liver Cancer

-Two independent antisense oligonucleotides (ASOs) targeting GREB1 and Arl4c gene-

Cancer vaccine (gene therapy) using adenoviral vector (Ad-REIC)